Log in or Sign up for Free to view tailored content for your specialty!
Pediatric Neurology News
VIDEO: Child Neurology Society addresses sexual, gender minority health care
Sexual and gender minority health care in child neurology is “such an important topic that just hasn’t gotten enough attention,” according to Ariel Maia Lyons-Warren, MD, PhD.
VIDEO: Conference reviews year of advances in child neurology
Ariel Maia Lyons-Warren, MD, PhD, an instructor of child neurology at Baylor College of Medicine and Texas Children’s Hospital, discusses what stood out to her at the Child Neurology Society annual meeting in Vancouver.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Agamree for Duchenne muscular dystrophy
The FDA has approved a 40 mg/mL oral suspension of Agamree to treat Duchenne muscular dystrophy in patients aged 2 years and older, according to a release from the manufacturer.
Ecopipam significantly reduces motor, vocal tics in Tourette syndrome
Ecopipam, a novel investigational compound for central nervous system disorders significantly reduced symptoms of Tourette syndrome in a cohort of pediatric patients, according to the manufacturer.
VIDEO: 'Big emphasis' on sleep medicine, mitochondrial disorders at CNS annual meeting
Robert C. Stowe, MD, an instructor of neurology at Boston Children’s Hospital and Harvard Medical School, discusses highlights from the Child Neurology Society annual meeting in this Healio video.
Odds of patients with MIS-C experiencing shock have fallen
Hospitalized patients with multisystem inflammatory syndrome in children — or MIS-C —are far more likely to experience shock than those hospitalized with Kawasaki disease, according to a study.
Babies with spinal muscular atrophy able to sit up after 1 year of Evrysdi treatment
Genentech has announced positive results from its primary analysis of an ongoing study assessing safety and efficacy of Evrysdi in babies with pre-symptomatic spinal muscular atrophy.
FDA removes partial clinical hold on IND for rare pediatric disease drug-device combo
A Bay Area biotech company announced the FDA has lifted the partial clinical hold on EryDel SpA’s investigational new drug application for EryDex to treat ataxia-telangiectasia, a rare pediatric neurological disorder.
Parental concerns over MiraLAX laxative continue to spur closer review
Constipation is a relatively common problem in pediatric practice, with reported prevalence rates between 1% and 30%, as well as the chief complaint in 3% to 5% of visits to pediatric outpatient clinics. Because most constipation cases can be remedied through recommended over-the-counter laxatives, constipation is rarely a cause for severe worry among parents.
Q&A: Screening all newborns for neurodevelopmental disorders comes with risks
Expanding newborn screening to identify genes associated with an increased risk for neurodevelopmental disorders could exacerbate disparities, among other drawbacks, experts wrote in Pediatrics.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read